Neurovascular Embolization Devices Market

Neurovascular Embolization Devices Market Insights, Competitive Landscape and Market Forecast-2030 report provides the current and forecast market outlook.

LAS VEGAS, NV, UNITED STATES, December 16, 2024 /EINPresswire.com/ -- According to DelveInsight’s analysis, The growing demand for neurovascular embolization devices is primarily driven by the increasing incidence of brain hemorrhages and blood vessel abnormalities, such as brain aneurysms and arteriovenous malformations (AVMs), which are linked to sedentary lifestyles. Additionally, factors such as the aging population, the rising prevalence of high blood pressure, and the introduction of new embolization products are contributing to the expansion of the global neurovascular embolization devices market.

Explore the future of healthcare innovation with our comprehensive Neurovascular Embolization Devices Market Landscape. Stay ahead in the industry!

DelveInsight's “Neurovascular Embolization Devices Market Insights, Competitive Landscape and Market Forecast-2030” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Neurovascular Embolization Devices companies actively working in the market.

Neurovascular Embolization Devices Overview
Neurovascular embolization devices are medical tools used in interventional procedures to treat conditions affecting the blood vessels in the brain. These devices are designed to block or occlude blood flow to specific areas, often to treat aneurysms, arteriovenous malformations (AVMs), or tumors. The devices include coils, particles, or other materials that are introduced into the blood vessels through a catheter. By selectively blocking blood flow to targeted areas, neurovascular embolization helps prevent hemorrhages, reduce the size of tumors, and manage other vascular abnormalities in the brain. These devices play a crucial role in minimally invasive neurointerventional procedures.

Neurovascular Embolization Devices Market Insights
The neurovascular embolization devices market is experiencing growth due to the rising incidence of hemorrhages and brain aneurysms. According to the National Health Service (NHS), factors such as smoking, severe head injuries, cocaine use, and high blood pressure increase the risk of developing brain aneurysms, which in turn boosts the demand for neurovascular embolization devices. For example, the World Health Organization (WHO) reported in 2021 that approximately 1.28 billion adults aged 30-79 worldwide suffer from hypertension, further contributing to the growing need for these devices. These factors are expected to boost product demand and fuel market growth from 2024 to 2030.

DelveInsight Analysis: The global neurovascular embolization devices market size was valued at USD 1.29 billion in 2023 and is projected to grow at a CAGR of 3.50% from 2024 to 2030, reaching USD 1.59 billion by 2030.

To know more about why North America is leading the market growth in the Neurovascular Embolization Devices market, get a snapshot of the report Neurovascular Embolization Devices Market Trends
https://www.delveinsight.com/report-store/neurovascular-embolization-devices-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Neurovascular Embolization Devices Market Report
• In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. ("MicroPort^® NeuroTech") has obtained registration certificates from China's National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System, designed for the minimally invasive treatment of cerebral aneurysms through neurovascular intervention.
• In April 2020, Cerus Endovascular has obtained CE Mark approval for its Neqstent Coil Assisted Flow Diverter device, intended for the treatment of intracranial aneurysms.
• In May 2019, Rapid Medical, a company specializing in next-generation neurovascular devices, has received FDA clearance for its Comaneci device, designed as a temporary coil embolization assist device.

To read more about the latest highlights related to Neurovascular Embolization Devices, get a snapshot of the key highlights entailed in the Neurovascular Embolization Devices Market Forecast Report

Key Players in the Neurovascular Embolization Devices Market
Some of the key market players operating in the Neurovascular Embolization Devices market include- Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

COVID-19 Impact Analysis on the Neurovascular Embolization Devices Market
According to estimates, North America is projected to hold a significant share of the global neurovascular embolization devices market in the coming years. This dominance is attributed to the growing prevalence of the target population in the region. Additionally, the presence of major market players and the recent introduction of embolization products are expected to drive the growth of the neurovascular embolization market in the region.
Additionally, The COVID-19 pandemic has significantly impacted the neurovascular embolization devices market. The implementation of lockdowns, social distancing measures, and containment protocols in various countries led to a slowdown. Additionally, the suspension of surgeries, reduced hospitalizations for subarachnoid hemorrhage (SAH), and fewer ruptured aneurysm coiling procedures, all aimed at preventing the virus spread, further hindered market growth. Healthcare professionals' shift in focus to managing the pandemic, along with the saturation of intensive care units (ICUs) due to the surge in COVID-19 patients, also affected the market. So, during the projected period, the market for Neurovascular Embolization Devices is anticipated to continue expanding (2024-2030).

Which MedTech key players in the Neurovascular Embolization Devices market are set to emerge as the trendsetter explore @ Neurovascular Embolization Devices Manufacturer

Scope of the Neurovascular Embolization Devices Market Report
• Coverage: Global
• Study Period: 2021–2030
• Neurovascular Embolization Devices Market Segmentation By Product Type: Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents and Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others
• Neurovascular Embolization Devices Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers
• Neurovascular Embolization Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Neurovascular Embolization Devices Companies: Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Table of Contents
1 Neurovascular Embolization Devices Market Report Introduction
2 Neurovascular Embolization Devices Market Executive summary
3 Regulatory and Patent Analysis
4 Neurovascular Embolization Devices Market Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
7 Neurovascular Embolization Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Company and Product Profiles
10 Neurovascular Embolization Devices Market Drivers
11. Neurovascular Embolization Devices Market Barriers
12. Project Approach
13. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.